JONATHAN S GOLDBERG MD NPI 1134172349

NPI Information

  • NPI: 1134172349
  • Provider Name: JONATHAN S GOLDBERG, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 185 ROUTE 312
    BREWSTER, NY
    ZIP 10509
  • Phone: (845) 231-5600

Map and Directions

Get Directions

NPI Details

Jonathan S Goldberg, MD is a hematology and oncology internal medicine in Brewster, NY with 32 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jonathan S Goldberg, MD NPI is 1134172349. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

185 ROUTE 312
BREWSTER, NY
ZIP 10509-337
Phone: (845) 231-5600
Fax: (845) 231-5489

The NPI 1134172349 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Magnesium level (HCPCS:83735)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Unclassified drugs (HCPCS:J3490)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Phosphate level (HCPCS:84100)
  • Uric acid level, blood (HCPCS:84550)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Iron binding capacity (HCPCS:83550)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Red blood count, automated test (HCPCS:85045)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Bilirubin level, direct (HCPCS:82248)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Iron level (HCPCS:83540)
  • Hepatitis b core antibody measurement (HCPCS:86704)
  • Hepatitis b surface antibody measurement (HCPCS:86706)
  • Measurement of hepatitis a antibody (HCPCS:86708)
  • Hepatitis c antibody measurement (HCPCS:86803)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • Platelet count, automated test (HCPCS:85049)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Blood test, clotting time (HCPCS:85610)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
  • Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)

The enumeration date for this NPI number is 5/18/2006 and was last updated on 11/17/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine201960NEW YORKNo
2207RX0202XInternal MedicineMedical Oncology201960NEW YORKNo
3207RH0003XInternal MedicineHematology & Oncology201960NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
102138498MEDICAIDNEW YORK
2P00232099OTHERNEW YORKMEDICARE RAILROAD
324N001MEDICARE PINNEW YORK
40667910001OTHERNEW YORKDME
524N0006761MEDICARE PINNEW YORK

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.